Cite
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group.
MLA
Coenen, Eva A., et al. “Pediatric Acute Myeloid Leukemia with t(8;16)(P11;P13), a Distinct Clinical and Biological Entity: A Collaborative Study by the International-Berlin-Frankfurt-Münster AML-Study Group.” Blood, vol. 122, no. 15, Oct. 2013, pp. 2704–13. EBSCOhost, https://doi.org/10.1182/blood-2013-02-485524.
APA
Coenen, E. A., Michel Zwaan, C., Reinhardt, D., Harrison, C. J., Haas, O. A., de Haas, V., Mihál, V., De Moerloose, B., Jeison, M., Rubnitz, J. E., Tomizawa, D., Johnston, D., Alonzo, T. A., Hasle, H., Auvrignon, A., Dworzak, M., Pession, A., van der Velden, V. H. J., Swansbury, J., & Kit-fai Wong. (2013). Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group. Blood, 122(15), 2704–2713. https://doi.org/10.1182/blood-2013-02-485524
Chicago
Coenen, Eva A., C. Michel Zwaan, Dirk Reinhardt, Christine J. Harrison, Oskar A. Haas, Valerie de Haas, Vladimir Mihál, et al. 2013. “Pediatric Acute Myeloid Leukemia with t(8;16)(P11;P13), a Distinct Clinical and Biological Entity: A Collaborative Study by the International-Berlin-Frankfurt-Münster AML-Study Group.” Blood 122 (15): 2704–13. doi:10.1182/blood-2013-02-485524.